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Abstract
Background: Since its isolation, Methicillin-resistant Staphlococcus aureus (MRSA) has become a major cause of
hospital acquired infection (HAI), adverse patient outcome and overall resource utilisation. It is endemic in Scotland
and widespread in Western hospitals. MRSA has been the subject of widespread media interest- a manifestation of
concerns about sterile surgical techniques and hospital cleanliness. This study aimed to investigate patient
outcome of MRSA infections over the last decade at a major orthopaedic trauma centre. The objective was to
establish the association of variables, such as patient age and inpatient residence, against patient outcome, in
order to quantify significant relationships; facilitating the evaluation of management strategies with an aim to
improving patient outcomes and targeting high-risk procedures.
Methods: This is a retrospective study of the rates and outcomes of MRSA infection in orthopaedic trauma at the
Royal Infirmary of Edinburgh. Data was collated using SPSS 14.0 for Windows(R). Shapiro-Wilkes testing was
performed to investigate the normality of continuous data sets (e.g: age). Data was analysed using both Chi-
Squared and Fisher’s exact tests (in cases of expected values under 5)
Results: This study found significant associations between adverse patient outcome (persistent deep infection,
osteomyelitis, the necessity for revision surgery, amputation and mortality) and the following patient variables: Length
of inpatient stay, immuno-compromise, pre-admission residence in an institutional setting (such as a residential nursing
home) and the number of antibiotics used in patient care. Despite 63% of all infections sampled resulting from
proximal femoral fractures, no association between patient outcome and site of infection or diagnosis was found.
Somewhat surprisingly, the relationship between age and outcome of infection was not proved to be significant,
contradicting previous studies suggesting a statistical association. Antibiotic prophylaxis, previously identified as a factor
in reducing overall incidence of MRSA infection, was not found to be significantly associated with outcome.
Conclusions: Early identification of high-risk patients as identified by this study could lead to more judicious use of
therapeutic antibiotics and reductions in adverse outcome, as well as socioeconomic cost. These results could
assist in more accurate risk stratification based on evidence based evaluation of the significance of the risk factors
investigated.
Introduction
The results of surveillance of 41,242 operations for sur-
gical site infections in orthopaedic surgery (SSIS), (April
2007 to March 2008), showed that 48% of SSIs were
caused by Staph. Aureus, of which 68% were MRSA [1].
As of early 2007, the number of deaths in the United
Kingdom attributed to MRSA was estimated to be
around 3,000 annually [2].
Research on MRSA has tended to concentrate on epi-
demiology, rather than outcomes. The cost of orthopae-
dic infection is considerable, with a retrospective study,
conducted by a single District General Hospital in 2008
estimating the annual cost of MRSA infection in its’
orthopaedic setting to be almost £390,000 [3].
Despite debate as to the virulence of methicillin-resis-
tant Staphylococcus aureus (MRSA) when compared
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mortality of MRSA bacteraemia are thought to be higher
than those associated with MSSA [4].
Methods
This study is a retrospective review of admissions over
an 11 year period from 1
st March 1999 in the Trauma
Department of Orthopaedic Surgery at the Royal Infirm-
ary of Edinburgh. Over this period, there were 37960
‘trauma’ (emergency, non elective) admissions to the
unit requiring surgical intervention. Of these, there were
404 MRSA post-operative wound infections and an
additional 254 patients were noted as being ‘colonised’
by MRSA. Overall incidence of MRSA wound infection
over this period was 1.06%. Our randomised sample
included 15% of all cases over this period. Patient details
were retrospectively collatedf r o ma no r t h o p a e d i cd a t a -
base for name, date of birth, gender, immunocompro-
mise, diabetes, pre-admission residence (home or
institutional setting), diagnosis, time from injury to pro-
cedure, use of arthroplasty, length of inpatient residence,
number of antibiotics used, concomitant surgical site
infection (SSI), number of revision procedures and site
of post-surgical infection. Additional note was taken if
therapeutic serum Vancomycin levels had been
monitored.
Definitions
Positively identified MRSA cases were classified as
superficial or deep with respect to the location of the
specimen site [see Figure 1].
Data Collection and Statistical Analysis
Cases were imported to SPSS 14.0 for Windows
®.D a t a
was analysed using Chi-Squared testing. Patients were
grouped into categories for ’age’ and ’time from original
injury’. Values are given to three significant figures,
except for p-values, which are given to two decimal
places. Patient outcome was assessed for significance (p
< 0.05) and strength of association (using Cramer’sV
values). We utilised a simple binary system, categorising
a ‘good’ outcome (e.g. discharge without complication)
as a ‘0’ and an adverse outcome (e.g. necessary revision
surgery due to deep post operative infection) as a ‘1’
[see Figure 2]. This allowed us to calculate mean post
operative outcomes, which we subsequently compared
to a number of patient variables and co-morbidities [see
Figure 3].
Results
We identified a randomised sample of 61 orthopaedic
trauma admissions over the period January 1998 to
March 2009. 59% of patients experienced ‘good’ out-
comes to their infections, whilst 41% suffered ‘adverse’
outcomes (definitions above). Associations between vari-
ables and patient outcome were investigated at the 95%
significance level (p < 0.05)
Risk Factors
We demonstrated a significant association between
patient immuno-compromise and adverse outcome (x
2=
4.92 p = 0.026). 58% of immuno-compromised patients
had adverse outcomes, compared to 30% of patients
without impaired immunity. This relationship was sig-
nificant, but of a moderate strength (Cramer’sV :
0.284) [Figure 4].
Pre-admission residence is a well documented factor
in MRSA incidence and a significant association with
patient outcome was shown. (x
2= 4.45, p = 0.035).3 2 %
of patients admitted from home had adverse outcomes,
compared to 40% of patients admitted from an institu-
tional setting, such as a nursing home or another hospi-
tal ward. [Figure 5]. This association was significant,
even when randomising for the high mean age of
patients admitted from institutional settings. (x
2=3 . 7 5 ,
p = 0.045 Cramer V = 0.394). The latter had a risk
r a t i o( R R )o f1 . 2 5o fe x p e r iencing adverse outcomes
when compared to patients admitted from home.
Length of Inpatient residence (LOS) was found to
be significantly associated with adverse outcome. (x
2=
8.87, p = 0.03 Cramer V = 0.458). This association was
the strongest of all the variables tested [Figure 3]. 62%
of patients with an LOS greater than 30 days suffered
adverse outcomes compared to 24% of patients with an
LOS less than 30 days. The distribution of LOS in
MRSA patients was positively skewed against normality
with a median LOS of 27 days compared to 4 days of




Past studies have suggesting a higher incidence of post-
operative MRSA infections in males [4]. 38% of our
cohort was male and 62% female. We found no signifi-
cant relationship between gender and outcome (x
2=
DEEP  SUPERFICIAL 
Bacteraemia 
Joint Aspirate 
Bone/Soft Tissue specimens 
Surgical Implant 
Deep wound/intraoperative swabs 
Surface wound swab 
Surface Exudates 
Figure 1 Classification of MRSA Infections/Colonisation.
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Page 2 of 60.52, p-value = 0.819). The predominance of elderly
patients in orthopaedic trauma is well established.
Whilst 72% of our cohort were over the age of 65 on
admission, (mean age: 70.2 yrs) 29% of patients under-
65’s were female, compared to 75% over the age of 65.
This perhaps relates to behavioural patterns and inci-
dence of traumatic injuries through risk taking beha-
viours amongst younger men, as well as the rates of
osteoporosis and cortical degeneration in older women.
[Figure 6].
The mean age of the cohort with a ‘good’ outcome
was 71, while the mean age of the ’adverse’ outcome
subset was 69. Contrary to the findings of previous
work, we found no significant association. (x
2= 0.001 p
= 0.985) [6].
No significant relationship was found between anti-
biotic prophylaxis and outcome (x
2= 8.80; p = 0.348).
Indeed, 36% of those who were not given prophylactic
antibiotics had an adverse outcome, compared to 44% of
those who did receive prophylaxis. However, older
patients appeared more likely to receive prophylaxis
than younger patients and also were also more likely to
have their daily serum Vancomycin levels monitored on
a more frequent basis. However, this association was not
significant. (x
2= 3.42 p = 0.064)
There was no significant association between diabetes
or arthroplasty use and outcome (x
2= 1.36 p = 0.730).
40% of non-diabetics and 50% of diabetics suffered
adverse outcomes, but this association was not signifi-
cant (Fisher’s exact test p-value 0.642).N os i g n i f i c a n t
association was found between time from injury to
procedure and patient outcome. (Fisher’se x a c tp -
value 0.823)
No significant association was found between site of
infection and patient outcome (Fisher’s p value 0.562).
Superficial wound infectionw a sf o u n dt ob ea s s o c i a t e d
with best mean outcomes, while neck of femur (NOF)
fracture wounds and other lower limb wounds were
Figure 3 Patient outcome against Patient Variable (Length of
In-patient stay).
‘GOOD’ PATIENT OUTCOMES  ‘BAD’ PATIENT OUTCOMES 
  Superficial infectionresultant in complete 
resolution with no long term sequelae 
  Persistent deep infection,  
  Osteomyelitis 
  Infection resulting in revision surgery or 
debridement/washout 
  Amputation  
  Mortality.   
Figure 2 Classification of post operative clinical outcomes.
Figure 4 Immuno-compromise against patient outcome.
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Page 3 of 6associated with worse outcomes [Figure 7]. 63% of all
cases involved extracapsular and intracapsular hip frac-
tures. 68% of these cases were in females and 89% of
these cases were in patients over the age of 65. Overall,
37% of intracapsular and extracapsular hip fractures
were linked to adverse outcomes.
Despite the high frequency of MRSA infection asso-
ciated with proximal neck of femur fractures, especially
in the elderly, no significant association was found
between diagnosis and the outcome of infection. (x
2=
3.63 p = 0.459) [4].
Discussion
The increasing incidence of MRSA colonisation in
patients from institutional settings is well documented
and rates of nosocomial MRSA infection have increased
over the past decade according to numerous studies
[5,7]. However, data on the effect of relevant variables
on mortality, (rather than epidemiology) is more sparse.
Post-operative MRSA infection stabilised in 2006, with
the number of UK MRSA related deaths peaking at
1652 in 2006, up from 51 in 1993. Changes in reporting
practices comprise a proportion of this change, but an
upward trend is still apparent.
Associations with Patient Outcome
Site of Pre-Admission Residence
This is particularly significant, given the high mean age
and proportion of patients from institutional settings.
Interestingly, heterogeneity between institutional settings
is noted. Data from the Office of National Statistics
showed a Risk Ratio (RR) of 8.0 for MRSA colonisation
in patients from NHS nursing homes, compared to
patients from private care homes. Much of the evidence
for United Kingdom guidelines for MRSA prevention in
healthcare facilities was generated in acute care settings
and may not be directly transferable to the nursing
home environment. However, the incidence of colonisa-
tion in residential patients is comparable to that of hos-
pitalised populations and patients transferred from long-
term care facilities to hospital often act as nosocomial
reservoirs of MRSA [5,6]. Additionally, there is a sugges-
tion of possible latent acquisition of deep post operative
wound infection from colonisation as a result of prior
repeated exposures to healthcare facilities and residential
settings which could explain this trend [8]. This conclu-
sion reinforces the importance of preventing initial
MRSA colonisation in this high risk group by judicious
use of prophylactic antibiotic therapy.
Figure 6 Gender against patient outcome.
 
 
Figure 5 Preadmission residence against patient outcome.
Figure 7 Infection Site against patient outcome.
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The association between LOS and staphylococcal infection
is well substantiated. Research has demonstrated that
MRSA infected patients suffer increased length of hospita-
lisation when compared to uninfected patients [9]. Evi-
dence has identified healthcare workers as possible
reservoirs for nasal colonisation a factor known to predis-
pose to increased risk of post-operative wound infection,
especially in the elderly [10,11]. In the UK, the most com-
mon strains of MRSA are EMRSA15 and EMRSA16 [12].
The latter has been particularly successful in developing
resistance to erythromycin and ciprofloxacin and surviving
intracellularly and is thought to be more prevalent in
healthcare workers than the general population [13].
There is a suggestion that MRSA infection impairs
post operative wound healing and it is unclear whether
the association with LOS is a cause or result of infection
[14]. Further investigation could monitor LOS before
initial isolation of a MRSA, but there are difficulties in
identifying the exact onset of wound infection. Patients
from the poorest socio-economic backgrounds are
reportedly up to seven times more likely to get post-
operative infection with MRSA than more affluent social
groups, possibly reflecting frequency of hospital admis-
sions, rather than CA-MRSA infection [15]. Further
study of individuals with frequent inpatient admissions
and the outcomes of any subsequent MRSA infection
could result in better screening of such individuals.
Number of antibiotics used and monitored serum
Vancomycin
A variety of studies have suggested that antibiotic expo-
sure may be a risk factor of MRSA isolation but the
association with mortality is less well defined [16]. One
study in particular highlighted a 1.8 fold increase in
MRSA isolation in patients prescribed more than 2 anti-
biotics in the last 180 days [16]. Clearly, patients with
more perceivably dire clinical prognosis could be mana-
ged by more antibiotics and it is unclear whether this
association is a cause or a result of a developing
outcome.
Interestingly, monitoring serum vancomycin levels was
not found to be linked to positive outcomes. Studies
have shown that the empirical use of Vancomycin may
not be judicious in MRSA and may increase mortality,
especially when responsible strains have a high vanco-
mycin MIC (minimum inhibitory concentration). Even
when MRSA is susceptible to vancomycin [MIC ≤ 2 μg/
mL], in treating MRSA bacteraemia is not unusual, due
to changes in the MIC or heteroresistance. For patients
with sepsis in MRSA bacteraemia, appropriate selection
of empirical antimicrobial treatment has been shown to
be a major prognostic factor [16]. In these cases, newer
anti-staphylococcal agents, such as linezolid and dapto-
mycin could be superior to vancomyin [15,17].
Immunocompromised Patients and Diabetes
Research on the impact of immunocompromise on
MRSA outcome is surprisingly scant. Studies regarding
patients with upper thoracic cancers have linked MRSA
infection (40%) in post-operative patients with signifi-
cant morbidity [3]. A study has suggested a link between
HIV and community acquired MRSA(CA-MRSA). It
highlighted a 2-fold increase in adverse outcomes in
immunocompromised patients, a conclusion broadly
supported by our study [18].
Our results were not sufficiently statistically significant
to support an association between diabetes and clinical
outcome. (Past studies suggest an association between
diabetes and SSI’s) [19]. Our results may have been
hampered by our sample size, but our validity was
improved by correction for the high mean age of
patients with diabetes and MRSA isolation.
Other Interesting and Negative Findings
No significant association was found between age and
outcome. This contradicts research suggesting an
increase in mortality with age in MRSA patients. (A
recent study suggested an odds ratio of mortality of 2.74
(95% confidence interval) for >75 compared with ≤60 yr
old patients) [3]. The distribution of age in MRSA infec-
tion in our sample was heavily positively skewed. As a
result, our small sample size resulted in a low number
of patients below the age of 65, reducing the significance
of our results in this subset.
Conclusion
This study highlights associations between outcome and
immunocompromise, length of inpatient stay and pre-
admission residence, which are significant and substan-
tiated by past studies. These conclusions suggest that tar-
geted MRSA prophylaxis should be offered to high risk
patients identified by appropriate risk stratified techni-
ques, based on the risk factors noted in results. My lit-
erature review has shown the overall scarcity of
literature related to outcome of MRSA infection and in
the context of a wealth of information regarding the epi-
demiology, more comprehensive research is needed.
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